Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment.
Vascul Pharmacol
; 155: 107295, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38985597
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoplasmic Reticulum Calcium-Transporting ATPases
/
Heart Failure
Limits:
Animals
/
Humans
Language:
En
Journal:
Vascul Pharmacol
Journal subject:
ANGIOLOGIA
/
FARMACOLOGIA
Year:
2024
Type:
Article
Affiliation country:
Italy